Professor Mark Cooper

University of Sydney, Anzac Research Institute
Concord Repatriation General Hospital
Hospital Road
Concord.  NSW.  2139.

Mark Cooper is Prof of Medicine and Head of Medicine at the Concord Clinical School, University of Sydney. He heads the Adrenal Steroid Lab at the ANZAC Research Institute. Until 2012 he was a Senior Lecturer at the University of Birmingham, UK. and metabolic bone physician at the Royal Orthopaedic Hospital, one of the largest orthopaedic hospitals in Europe. His clinical and research interests include adrenal steroid physiology and metabolic bone disease. In particular, he examines the role that glucocorticoid metabolism plays in normal physiology, inflammatory arthritis and glucocorticoid induced osteoporosis. He was previously the Bertram Abraham’s Lecturer in Physiology at the Royal College of Physicians of London. He has served on committees for the ASBMR and ECTS. He continues to combine a clinical practice with a basic/translational research group.

Associate Professor Rachel Davey

Associate Professor Rachel A Davey, PhD
Head, Molecular Endocrinology and Musculoskeletal Research Group
Department of Medicine, Austin Health
The University of Melbourne
Level 7, Lance Townsend Building
Studley Road
Heidelberg Victoria 3074
Australia

Associate Professor Rachel Davey completed her PhD in Physiology at The University of Adelaide in 1998, studying the effects of estrogens and androgens on bone cell metabolism. Associate Professor Davey is currently Head of the Molecular Endocrinology and Musculoskeletal Research Group in the Department of Medicine, Austin Health at the University of Melbourne.

Associate Professor Davey’s research focusses on the cellular and molecular pathways through which hormones act in the musculoskeletal system with a particular focus on androgens and calcitonin. She has over 50 publications spanning areas of bone and muscle biology and metabolism. In recognition of her research and teaching achievements, she was the first Australian to be awarded the American Society of Bone and Mineral Research Early Career Teaching Award (2008), the inaugural recipient of the Endocrine Society of Australia Mid-Career Award (2009) and the recipient of an ANZBMS mid-career fellowship in 2017.

Scientific Involvement (selected):
Member ANZBMS, 1997-current.
Member ASBMR, 2004 – current.
Member ESA, 1999 – current.
Co-chair of the Programme Organising Committee, ANZBMS Scientific Meeting, 2018 and 2019.
Member of the Programme Organising Committee and Local Organising Committee, ANZBMS 2013.

Assoc Professor Dawn Coates

Faculty of Dentistry | Te Kaupeka Pūniho 
Sir John Walsh Research Institute 
University of Otago | Te Whare Wānanga o Otāgo 
Dunedin 
New Zealand | Aotearoa

Dr Coates is a molecular and cellular biologist with 28 years of experience in osteogenesis, angiogenesis, and stem cell biology. After completing a PhD at Otago University she undertook postdoctoral positions with AgResearch (Wallaceville, NZ) and at Cambridge University. Dr Coates is Deputy Associate Dean of Research within the Dental Faculty (University of Otago, NZ), and is Director of DEnTRegen (Dental Engineering and Tissue Regeneration), a programme which produces novel bioengineered constructs for bone and tissue regeneration. Dr Coates has a focus on 3D-bioprinting of constructs and the development of novel bovine graft materials for bone regeneration. These materials are modified to provide additional benefit with the addition of antimicrobial agents such as nanosilver particles and triketones. Research on BRONJ (Bisphosphonate-Related Osteonecrosis of the Jaw) and the angiogenic and osteogenic genes involved, identified geranylgeraniol as a drug that can correct the molecular pathway affected in this serious condition. Stem cell projects include research with dental pulp stem cells, adipose-derived stem cells, periosteal stem cells, and deer antler stem cells as a model system. The use of proteomics and gene analysis in combination in vitro assays has enable new insights into these fascinating cells.

Professor Mark Forwood

Griffith University Gold Coast
School of Medical Science
Griffith University
QLD.  4222.

Professor Forwood was appointed as the Foundation Chair of Anatomy at Griffith University in 2009, and Head, School of Medical Science from 2013 to 2021. His laboratory studies skeletal adaptation, mechanotransduction and bone quality, funded by grants from National Health and Medical Research Council since 1996. He was a NHMRC Fellow at Indiana University with David Burr and Charles Turner at IUPUI from 1991-1994. Following his Fellowship, Prof Forwood returned to the The University of Queensland, where he continued his research in skeletal biology and taught gross and musculoskeletal anatomy. Mark was first elected to ANZBMS Council in 1997 and became Treasurer from 1999-2005. He has been a member of the Board of Directors of the International Federation of Musculoskeletal Research Societies since 2017 and Chair of the IFMRS International Education Working Group. He is on the Editorial Board of Bone and was a section editor for Current Osteoporosis Reports. In 2016, he was elected as a Fellow of the Queensland Academy of Arts and Sciences, and in 2019 a Fellow of the ASBMR.

Dr Michelle McDonald

Garvan Institute

384 Victoria St
Darlinghurst.  NSW. 

Dr Michelle McDonald’s research careers spans over 19 years, attaining her PhD in 2008. She is currently Group Leader of the Bone Microenvironment Group at The Garvan Institute, Sydney, Australia. Through the development of a novel intravital imaging technique her research has allowed, visualisation and fate tracking of dormant and actively growing tumour cells within living bone, as well as visualisation of bone cells in real time. This approach has revealed previously unappreciated bone osteoclast dynamics, and uncovering mechanisms behind unexpected clinical responses to anti-resorptive therapies, which was recently accepted in Cell. Combined with her experience using therapeutic agents to modulate bone cell activity, her group is working to define how these agents can be repurposed to prevent tumour-induced bone destruction and prevent tumour growth through regulating the bone micro-environment. Michelle regularly perform peer reviews, sits on the editorial boards and holds positions on international scientific committees.

Dr Melissa Cantley 

NHMRC Early Career Research Fellow | Faculty of Health and Medical Sciences
School of Biomedicine
The University of Adelaide
Myeloma Research Laboratory 
Precision Medicine Theme, Cancer Program - Level 5 South
SAHMRI, North Tce 
Adelaide, Australia

PhD

Dr Melissa Cantley completed her PhD in 2013 at the University of Adelaide with a project focussed on pathological bone remodelling. In 2014 Melissa was awarded a NHMRC Early Career Fellowship to work with Professor Zannettino in the Myeloma Research Laboratory at the University of Adelaide, located at the South Australian Health and Medical Research Institute (SAHMRI). Dr Cantley’s research interests revolve around bone cell biology and role of the complex bone microenvironment in disease. This has included in chronic inflammatory diseases such as rheumatoid arthritis and periodontitis where she has made significant research contributions in therapeutic targeting of pathogenic bone loss. Dr Cantley's current research is focussed on the blood cancer multiple myeloma and understanding the progression from pre-cancerous stages to cancerous myeloma. This involves unravelling the role of the complex bone marrow microenvironment in disease progression and discovering novel biomarkers that can be used to predict risk of progression in patients with the pre-cancerous stages of disease.  Dr Cantley has been Co-Chair of the ANZBMS Early Career Investigator Committee (ECIC) over the last two years and was a member of the Inaugural ANZBMS Early Career Investigator Newsletter Editorial Board (2019-2021). Dr Cantley has also been a member of the ANZBMS Program Organising Committee (POC) (2020-2021). Dr Cantley is a Director on the Australian Society for Medical Research (ASMR) National Board.

Assoc Professor Cherie Chiang

MBBS (Hons) FRACP FRCPA MAACB MD

Endocrinologist & Stream Leader Endocrine Chemical Pathology, Department of Diabetes and Endocrinology, Royal Melbourne Hospital.

Chemical Pathologist, Department of Pathology, Royal Melbourne Hospital.

Endocrinologist, Austin Hospital & Peter MacCallum cancer Centre Honorary Senior Fellow, The University of Melbourne

P: Department of Pathology, Royal Melbourne Hospital, Parkville VIC 3050.

Dr Chiang graduated with honours from Monash University. She completed her membership examination for Australasian Association of Clinical Biochemists in 2006 and her dual fellowships in FRACP and FRCPA in 2008. She was the recipient of the ASBMR Young Investigator Award in 2015. She completed her Doctor of Medicine (University of Melbourne) Doctorate by Research in 2018 on The Role of Androgens Acting via the Androgen Receptor in Osteoblasts to Regulate Bone Cell Metabolism. Her research interests and publications include Bone Turnover Markers, Vitamin D, bone microarchitecture and Atypical Femoral Fractures. She has broad clinical experience in management of skeletal disease in cancer, setting up of Fracture Liaison Service, and Bone Densitometry reporting. She is a RCPA examiner and the chair of the Harmonisation of Endocrine Dynamic Testing Working Party.

Professor Belinda Beck

Professor Belinda Beck 
School of Health Sciences and Social Work
Director, The Bone Clinic
Menzies Health Institute Queensland
Griffith University 

BHMS(Ed), MS, PhD

Belinda Beck is a Professor of Exercise Science in the Menzies Health Institute Queensland at Griffith University (Gold Coast, Australia) and Director of The Bone Clinic, a translational research facility and clinical practice providing for patients with osteoporosis. She graduated from The University of Queensland (BHMS[Ed]) and the University of Oregon (MSc and PhD) and completed a postdoctoral research fellowship in the Stanford University School of Medicine (CA, USA). Her work, primarily related to the effects of mechanical loading on bone, has involved both animal and human models, from basic to clinical research. Her particular focuses have been exercise interventions across the lifespan for bone health, in recent years developing the Onero exercise program for the prevention of osteoporotic fracture which is now delivered around the world. 

Professor Itamar Levinger

Associate Director Research and Research Training, Institute for Health and Sport (IHES), Victoria University, Leader: Bone, Muscle and CV Research Group, IHES.

PhD, MSc, B.Ed, AEP, Fellow ASBMR, Fellow ESSA

Prof Levinger is a Clinical Exercise Physiologist and the leader of the Bone-Muscle Interaction Research Group at the Institute for Health and Sport (IHES), Victoria University. He is also the Associate Director Research and Research Training, IHES. Itamar completed his PhD in 2008 and was awarded a Heart Foundation Postdoctoral fellowship between 2012-2014 and a Heart Foundation Future Leader Fellowship between 2014-2018. He developed extensive knowledge, skills and experience in the area of exercise rehabilitation for patients with sarcopenia and cardiometabolic diseases as well as muscle function and metabolism and cell signalling in humans and murine models. His current research focus on uncovering the mechanisms involved in bone-muscle interaction and the implication of such interaction for the development of sarcopenia, type 2 diabetes and cardiovascular disease.

Scientific Involvement (selected): Member ANZBMS, 2013-current, Member ASBMR, 2012 – current (Fellow ASBMR Since 2022), Member ESSA, 2008 – current (Fellow ESSA since 2014), Member AuPs, 2016-current.  Chair Local Organising Committee, ANZBMS 2021, Programme Organising Committee, ANZBMS Scientific Meeting, 2023.

Dr Marc Sim